PAVmed Inc. - Common (PAVM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2025

Type / Class
Equity / Common
Symbol
PAVM on Nasdaq
Shares outstanding
17,350,000
Price per share
$0.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,535,145
Total reported value
$662,767
% of total 13F portfolios
0%
Share change
+310,314
Value change
+$133,813
Number of holders
32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PAVmed Inc. - Common (PAVM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tasso Partners, LLC 19% $1,802,045 2,574,350 Tasso Partners, LLC 21 Feb 2025
Ayrton Capital LLC 9.9% $858,421 1,226,316 Ayrton Capital LLC 31 Dec 2024
Sargent Investment Group, LLC 5.8% $604,183 1,006,300 Sargent Investment Group, LLC 01 Jul 2025
FIRST MANHATTAN CO. LLC. 4.3% $499,870 714,100 FIRST MANHATTAN CO. LLC. 31 Mar 2025

As of 30 Sep 2025, 32 institutional investors reported holding 1,535,145 shares of PAVmed Inc. - Common (PAVM). This represents 8.8% of the company’s total 17,350,000 outstanding shares.

Institutional Holders of PAVmed Inc. - Common (PAVM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 1,535,145 $662,767 +$133,813 $0.43 32
2025 Q2 1,224,831 $735,397 +$3,569 $0.60 29
2025 Q1 1,211,515 $873,492 +$123,620 $0.72 30
2024 Q4 1,041,798 $653,834 -$49,628 $0.63 25
2024 Q3 1,120,689 $1,378,717 +$95,825 $1.23 22
2024 Q2 1,056,670 $861,151 +$57,582 $0.82 23
2024 Q1 952,389 $2,032,208 +$362,293 $2.14 22
2023 Q4 753,692 $3,104,938 +$3,104,938 $4.12 25